journal article

• Two Classes of Myosin Inhibitors, Para-nitroblebbistatin and Mavacamten, Stabilize β-Cardiac Myosin in Different Structural and Functional States.  Journal of Molecular Biology. 2021
• Myosin motor domains carrying mutations implicated in early or late onset hypertrophic cardiomyopathy have similar properties.  Journal of Biological Chemistry. 17451-17462. 2019
• Contractility parameters of human β-cardiac myosin with the hypertrophic cardiomyopathy mutation R403Q show loss of motor function.  Science Advances. 2015